Updates to COVID-19 Direction for 16 March 2021, South Australia

Updates have been made to the Prohibition of Certain Point of Care Tests Direction.

Prohibition of Certain Point of Care Tests No 2

The Prohibition of Certain Point of Care Tests No 2 Direction came into effect at 9am on Tuesday 16 March 2021.

The changes are:

  • People are prohibited from using a point of care serological (blood) test or a point of care antigen based or nucleic acid based (upper or lower respiratory tract specimen) test (including an assay or device) as an acute illness diagnostic tool for COVID-19. This is because the use of this testing type may adversely affect the prevention, control and abatement of the serious public health risk present by COVID-19.
  • This direction does not apply to employees of SA Pathology or the Department of Health and Wellbeing.

Other existing requirements remain. The information above only highlights the changes key made to the Directions and does not reflect all requirements. Members of the public are encouraged to see the full Directions for further information.

All existing directions, frequently asked questions and other information can be found here: https://www.covid-19.sa.gov.au/emergency-declarations

If you require further information you can call the SA COVID-19 Information Line on 1800 253 787 between the hours of 9am to 5pm 7 days per week or go to the SA Health website at www.sahealth.sa.gov.au or www.sa.gov.au/covid-19

The Emergency Management (Emergency Management (Prohibition of Point of Care Serology Tests) (COVID-19) Direction 2021 has been revoked and replaced by the Emergency Management (Prohibition of Certain Point of Care Tests No 2) (COVID-19) Direction 2021.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.